ClinConnect ClinConnect Logo
Search / Trial NCT05259566

Potential Impact of Menthol Ban in Cigarettes and E-cigarettes

Launched by YALE UNIVERSITY · Feb 17, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Menthol E Cigarette Cigarette

ClinConnect Summary

This clinical trial is studying the potential effects of a proposed ban on menthol cigarettes by looking at how menthol-flavored e-cigarettes may help people who currently smoke menthol cigarettes. The goal is to understand if having access to menthol e-cigarettes can help these smokers reduce their cigarette use or switch to e-cigarettes instead. This research is important because it can provide insights into how such a ban might impact smokers' behavior and health.

To participate in this study, you need to be at least 21 years old, currently smoke cigarettes, and be willing to try e-cigarettes. You should also be in good health and able to understand English. If you join, you'll be asked to provide your consent and follow the study guidelines. However, if you're looking for help to quit smoking or have serious health issues, this study may not be suitable for you. Being part of this trial could help researchers understand better ways to support menthol smokers in reducing their tobacco use.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Provision of signed and dated informed consent form
  • Age 21 or older
  • Able to read English
  • Currently smoking cigarettes
  • Willing to try e-cigarettes
  • In good general health
  • Exclusion Criteria:
  • Seeking smoking cessation treatment
  • Serious psychiatric or medical condition
  • Use of other drugs
  • Unable or unwilling to complete study protocol
  • Contraindications for study procedures based on medical history

About Yale University

Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.

Locations

New Haven, Connecticut, United States

New Haven, Connecticut, United States

Patients applied

0 patients applied

Trial Officials

Krysten Bold, PhD

Principal Investigator

Yale University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials